ArticleActa oncologica (Stockholm, Sweden)2024

NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial.

Jean-Matthieu L'Orphelin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.